Lansforsakringar Fondforvaltning’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Buy
5,458
+1,340
+33% +$93.3K ﹤0.01% 537
2025
Q4
$273K Sell
4,118
-36,180
-90% -$2.34M ﹤0.01% 548
2025
Q3
$2.71M Sell
40,298
-200
-0.5% -$15.8K 0.01% 467
2025
Q2
$3.54M Sell
40,498
-3,717
-8% -$291K 0.02% 444
2025
Q1
$3.02M Sell
44,215
-1,195
-3% -$97.5K 0.02% 462
2024
Q4
$3.53M Buy
+45,410
New +$3.36M 0.02% 455

Other funds holding DXCM

Lansforsakringar Fondforvaltning's DXCM Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning increased its DexCom (DXCM) stake by 33% in Q1 2026, buying an estimated $93.3K and bringing the position to 5,458 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Lansforsakringar Fondforvaltning first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.54M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 5,458 shares of DexCom worth $343K as of Q1 2026.
  • Lansforsakringar Fondforvaltning bought 1,340 DexCom shares in Q1 2026, an estimated $93.3K.
  • DexCom made up ﹤0.01% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #537 holding.
  • Lansforsakringar Fondforvaltning first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's DexCom position peaked at $3.54M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.